Browse: Home / Blood Pressure Treatment Benefits on Survival Persist for Years – New Findings in Patients with Type 2 Diabetes

Menu

Skip to content
  • Home
  • About Us
  • Contact Us
  • Submit News
Header image

Cambodian TribuneLogo

Latest Cambodian News

Menu

Skip to content
  • General
  • Economy
  • Information
  • Fashion
  • Self Care
  • Athletic
  • Domestic Affairs
  • Legal
  • PRESS RELEASES
  • Beijing House Church Pastor Denied Pension Amid Ongoing Crackdown on Worship
  • COVID-19: Another Patient Recovered
  • Economic Diplomacy Strategy 2021-2023 Launched
  • Hong Kong Healthcare Volunteer Jailed For Four Years Over 2019 Protest
  • Cambodian PM Receives Courtesy Call from New Indian Ambassador

Blood Pressure Treatment Benefits on Survival Persist for Years – New Findings in Patients with Type 2 Diabetes

Posted by admin on September 19, 2014 in Health Care | 27 Views

VIENNA, Sept. 19, 2014 /PRNewswire/ —

Report from the European Society of Cardiology Congress – September 2014 

Australian researchers have discovered that the reductions in heart events and death, from using blood pressure-lowering drugs in patients with type 2 diabetes, persist for many years after treatment has stopped.

The global study has found that, six years after stopping intensive treatment with the combination of perindopril and indapamide, patients with type 2 diabetes continued to have a lower risk of serious heart disease and death.

The study, titled ADVANCE-ON, was led by The George Institute for Global Health and held in 20 countries. It followed up more than 80 per cent of the 11,000 patients with diabetes who had been involved in the original ADVANCE trial that started in 2001 and finished in 2007.

In ADVANCE, patients whose blood pressure had been treated with ACE inhibitor-diuretic combination for nearly five years were found to have a reduced risk of death and heart events. In the follow-up ADVANCE-ON study, these benefits were still evident six years later, but reduced compared to those during active treatment.

Speaking at the European Cardiology Society Congress in Barcelona, Principal Investigator Professor John Chalmers, of The George Institute for Global Health and The University of Sydney, said: "The findings highlight the importance of active blood pressure lowering therapy for patients with type 2 diabetes. The good news is that the benefits last longer than the treatment. The even more important news is that active treatment is needed in both the short and the long term, in order to maximise the number of lives saved."

Study Director, Associate Professor Sophia Zoungas added: "This is a completely new finding for patients with type 2 diabetes, although it has previously been noted for patients with hypertension."

Professor Chalmers said the intensive treatment based on perindopril and indapamide was likely to have produced long lasting structural changes in the patient’s cardiovascular system.

Worldwide, it is estimated that 382 million people have diabetes and about 90 per cent of those have type 2 diabetes. Diabetes causes heart disease, blindness, kidney failure, limb amputation and stroke and is one of the top ten causes of death.

ADVANCE was funded by Australia’s National Health and Medical Research Council (NHMRC), the British Heart Foundation, Diabetes UK, and Servier.

Posted in Health Care | Tagged HEA, MTC

Related Posts

Missing imageDKSH Supports Growth for Vitabiotics in Hong Kong and Malaysia→

Missing imageSphenopalatine Ganglion Stimulation in the Pathway CH-1 Study Reduces Headache Burden Before and After Sustained Periods of Cluster Attack Remission→

Missing imageLatin American Contract Research Organizations Set to Get More Local Outsourcing Opportunities→

Missing imageJapan Helps Strengthen Community Healthcare in Kampong Cham Province→

Search

Pages

  • Home
  • About Us
  • Contact Us
  • Submit News

Categories

Calendar

January 2021
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Dec    

Advertisement

Latest News

  • Missing image

    Beijing House Church Pastor Denied Pension Amid Ongoing Crackdown on Worship

    January 18, 2021 / User2
  • Missing image

    COVID-19: Another Patient Recovered

    January 18, 2021 / User2
  • Missing image

    Economic Diplomacy Strategy 2021-2023 Launched

    January 18, 2021 / User2
  • Missing image

    Hong Kong Healthcare Volunteer Jailed For Four Years Over 2019 Protest

    January 18, 2021 / User2
  • Missing image

    Cambodian PM Receives Courtesy Call from New Indian Ambassador

    January 18, 2021 / User2
  • Missing image

    Sarus Crane Still Exist but Number Seeming Drop

    January 18, 2021 / User2
  • Missing image

    Japan Provides US$227,736 for Improving Firefighting Capability of Phnom Penh Administration

    January 18, 2021 / User2
  • Missing image

    COVID-19: Three Recovered; Three Infected

    January 17, 2021 / User2
  • Missing image

    PM Hun Sen to Be the First Volunteer for Chinese Vaccine

    January 17, 2021 / User2
  • Missing image

    Cambodia’s Mekong River Believed to be a Healthiest Habitat of Endangered Giant Freshwater Stingray

    January 17, 2021 / User2
  • Missing image

    COVID-19: 10 New Infections Reported

    January 16, 2021 / User2
  • Facebook
  • Pinterest
  • Tumblr
  • Twitter

Pages

  • About Us
  • Contact Us
  • Submit News

Categories

 

Recent Posts

  • Beijing House Church Pastor Denied Pension Amid Ongoing Crackdown on Worship January 18, 2021
  • COVID-19: Another Patient Recovered January 18, 2021
  • Economic Diplomacy Strategy 2021-2023 Launched January 18, 2021
 

Search

Archives

 

About Us

Cambodia Tribune is a website which acts as an information bank in which news and press releases from various sources are updated on a regular basis. The information is associated with Cambodia and features national news, business news, technological news and other news coverage.
 

©2021 Cambodian Tribune

Menu

  • Home
  • About Us
  • Contact Us
  • Submit News